Does HYDROCHLOROTHIAZIDE Cause Product packaging issue? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Product packaging issue have been filed in association with HYDROCHLOROTHIAZIDE (Irbesartan and Hydrochlorothiazide). This represents 0.0% of all adverse event reports for HYDROCHLOROTHIAZIDE.
7
Reports of Product packaging issue with HYDROCHLOROTHIAZIDE
0.0%
of all HYDROCHLOROTHIAZIDE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product packaging issue From HYDROCHLOROTHIAZIDE?
Of the 7 reports, 2 (28.6%) required hospitalization.
Is Product packaging issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HYDROCHLOROTHIAZIDE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does HYDROCHLOROTHIAZIDE Cause?
Hyponatraemia (2,138)
Drug ineffective (1,889)
Acute kidney injury (1,838)
Nausea (1,536)
Dyspnoea (1,521)
Dizziness (1,469)
Headache (1,419)
Hypotension (1,347)
Fall (1,323)
Malaise (1,312)
What Other Drugs Cause Product packaging issue?
ACETAMINOPHEN (448)
LOPERAMIDE (351)
DIMETHICONE\LOPERAMIDE (348)
USTEKINUMAB (221)
FENTANYL (200)
MINOXIDIL (173)
CETIRIZINE (166)
ESTRADIOL (163)
GOLIMUMAB (95)
CYCLOSPORINE (93)
Which HYDROCHLOROTHIAZIDE Alternatives Have Lower Product packaging issue Risk?
HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\IRBESARTAN
HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LISINOPRIL
HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LOSARTAN
HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\METOPROLOL
HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\NEBIVOLOL